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BACKGROUND  
• The use of ETCO2 during moderate sedation is an 
ENA Clinical Practice Guideline and best practice
• Following COVID-19, the ECC will begin to use ETCO2
in intubated patients to measure effectiveness of 
compressions and as a measure of ROSC
• The opportunity exists to improve the use of ETCO2
for moderate sedation
• Patients who predominately mouth breath result in 
the inability of nasal sensor to pick up ETCO2, this 





• Increase the utilization of ETCO2 during moderation 
sedation procedures. This will allow earlier 
identification of deterioration and allow RNs to 
intervene quicker
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Design: Evidence-based quality improvement
Participants: Emergency Care Center RNs
Procedure:
• Education provided to RNs using assigned modules 
and emailed power point presentations on the 
use, setup, indications and interventions of ETCO2
for patients receiving moderate sedation
• Self-auditing tool 
• Developed 
• Completed by primary RN performing a 
moderate sedation procedure
• Contents:
• Was a consent form signed for the 
procedure?
• Was ETCO2 used? If not, what is the reason?
• Was ETCO2 documented per policy? For how 
long?
• Was there an adverse event?
• Follow up and coaching was done when ETCO2
was not used or documented per policy
• Collection and Analysis: A minimum of six audits 
were preformed monthly on the records of 
patients receiving moderate sedation and use of 
ETCO2
• 23% of all audited charts between 9/19 -7/20 had 
ETCO2 documented per policy
• ETCO2 education was sent out in January, February 
and July 2020. The “Self Auditing Tool” was 
implemented in Feb 2021
• There was only a 30% use of ETCO2 for the month of 
Feb 2021, but for months March through July 2021, 
use of ETCO2 increased to 67%
• Jan and Feb 2021 had 41% use, RNs citing machine 
not available. In March, added two new machines 
which may have contributed to the increase in use 
and compliance
• ETCO2 use for July 2021 was 80%
• RNs noted and appropriately responded to 
abnormal ETCO2. Patient condition stabilized with 
return to baseline
• Short acting analgesia and sedation medications are 
used during many procedures in the Emergency 
Department (ED)
• Patients require close monitoring for abnormal vital 
signs and other adverse occurrences, such as 
respiratory depression and apnea
• Use of ETCO2 is recommended by the Emergency 
Nurses Association (ENA) for moderate sedation
• ENA evidence-based Clinical Practice Guideline 
(2015) determined that capnography during 
moderate sedation detects respiratory depression 
and apnea faster than vital signs, pulse oximetry, 
and clinical assessment during short acting 
analgesia and sedation
CONCLUSION
• The use of ETCO2 in theory and in practice is able 
to detect respiratory depression faster than pulse 
oximetry, allowing timely RN intervention with 
excellent patient outcomes
LOCAL CONTEXT
• Results of Emergency Care Center (ECC) medical 
record audits (9/1/19-7/30/20) found that only 
23% of patients undergoing moderate sedation 
had ETCO2 used during the procedure
